TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
hsa04010	MAPK signaling pathway	0.00034934929165573	-7.9594383005742	255	17	0.0939226519337017	181	6908	5599,2247,9175,3164,5922,4914,22808,785,7048,9252,9965,2122,5062,4616,776,1649,4208	MAPK8,FGF2,MAP3K13,NR4A1,RASA2,NTRK1,MRAS,CACNB4,TGFBR2,RPS6KA5,FGF19,MECOM,PAK2,GADD45B,CACNA1D,DDIT3,MEF2C
ko04010	MAPK signaling pathway	0.00034934929165573	-7.9594383005742	255	17	0.0939226519337017	181	6908	5599,2247,9175,3164,5922,4914,22808,9252,785,7048,9965,2122,5062,4616,776,1649,4208	MAPK8,FGF2,MAP3K13,NR4A1,RASA2,NTRK1,MRAS,RPS6KA5,CACNB4,TGFBR2,FGF19,MECOM,PAK2,GADD45B,CACNA1D,DDIT3,MEF2C
hsa04510	Focal adhesion	0.00101825247988109	-6.88966737600431	207	14	0.0773480662983425	181	6908	5599,6696,2534,3480,3673,5062,10319,1287,857,4233,1288,5291,1293,3914	MAPK8,SPP1,FYN,IGF1R,ITGA2,PAK2,LAMC3,COL4A5,CAV1,MET,COL4A6,PIK3CB,COL6A3,LAMB3
ko04510	Focal adhesion	0.00101825247988109	-6.88966737600431	207	14	0.0773480662983425	181	6908	5599,6696,2534,3480,3673,5062,10319,1287,857,4233,1288,5291,1293,3914	MAPK8,SPP1,FYN,IGF1R,ITGA2,PAK2,LAMC3,COL4A5,CAV1,MET,COL4A6,PIK3CB,COL6A3,LAMB3
hsa04512	ECM-receptor interaction	0.00190268137044179	-6.2644911400828	87	8	0.0441988950276243	181	6908	6696,3339,3673,10319,1287,1288,1293,3914	SPP1,HSPG2,ITGA2,LAMC3,COL4A5,COL4A6,COL6A3,LAMB3
ko04512	ECM-receptor interaction	0.00190268137044179	-6.2644911400828	87	8	0.0441988950276243	181	6908	6696,3339,3673,10319,1287,1288,1293,3914	SPP1,HSPG2,ITGA2,LAMC3,COL4A5,COL4A6,COL6A3,LAMB3
hsa03060	Protein export	0.00273269514450943	-5.90246692435767	23	4	0.0220994475138122	181	6908	58477,83943,29927,7095	SRPRB,IMMP2L,SEC61A1,SEC62
ko03060	Protein export	0.00273269514450943	-5.90246692435767	23	4	0.0220994475138122	181	6908	58477,83943,29927,7095	SRPRB,IMMP2L,SEC61A1,SEC62
hsa04151	PI3K-Akt signaling pathway	0.00402864840847073	-5.5143243417903	346	18	0.0994475138121547	181	6908	2247,3164,10319,1287,9586,5291,9965,5523,1293,3914,6696,3480,3673,4233,5522,5106,1288,285	FGF2,NR4A1,LAMC3,COL4A5,CREB5,PIK3CB,FGF19,PPP2R3A,COL6A3,LAMB3,SPP1,IGF1R,ITGA2,MET,PPP2R2C,PCK2,COL4A6,ANGPT2
ko04151	PI3K-Akt signaling pathway	0.00402864840847073	-5.5143243417903	346	18	0.0994475138121547	181	6908	2247,3164,10319,1287,9586,5291,9965,5523,1293,3914,6696,3480,3673,4233,5522,5106,1288,285	FGF2,NR4A1,LAMC3,COL4A5,CREB5,PIK3CB,FGF19,PPP2R3A,COL6A3,LAMB3,SPP1,IGF1R,ITGA2,MET,PPP2R2C,PCK2,COL4A6,ANGPT2
ko04973	Carbohydrate digestion and absorption	0.00610835827757838	-5.09809723624412	45	5	0.0276243093922652	181	6908	483,776,5330,5291,3099	ATP1B3,CACNA1D,PLCB2,PIK3CB,HK2
hsa04973	Carbohydrate digestion and absorption	0.00610835827757838	-5.09809723624412	45	5	0.0276243093922652	181	6908	483,776,5330,5291,3099	ATP1B3,CACNA1D,PLCB2,PIK3CB,HK2
hsa05146	Amoebiasis	0.00682117674962466	-4.98772327807752	107	8	0.0441988950276243	181	6908	384,7879,10319,1287,1288,5330,5291,3914	ARG2,RAB7A,LAMC3,COL4A5,COL4A6,PLCB2,PIK3CB,LAMB3
ko05146	Amoebiasis	0.00682117674962466	-4.98772327807752	107	8	0.0441988950276243	181	6908	384,7879,10319,1287,1288,5330,5291,3914	ARG2,RAB7A,LAMC3,COL4A5,COL4A6,PLCB2,PIK3CB,LAMB3
hsa05222	Small cell lung cancer	0.00710747286691802	-4.94660853197465	86	7	0.0386740331491713	181	6908	10319,1287,2272,1288,5291,3673,3914	LAMC3,COL4A5,FHIT,COL4A6,PIK3CB,ITGA2,LAMB3
ko05222	Small cell lung cancer	0.00710747286691802	-4.94660853197465	86	7	0.0386740331491713	181	6908	10319,1287,2272,1288,5291,3673,3914	LAMC3,COL4A5,FHIT,COL4A6,PIK3CB,ITGA2,LAMB3
hsa00280	Valine, leucine and isoleucine degradation	0.00735395711922435	-4.91251672706589	47	5	0.0276243093922652	181	6908	5096,217,1962,5095,56922	PCCB,ALDH2,EHHADH,PCCA,MCCC1
ko00280	Valine, leucine and isoleucine degradation	0.00735395711922435	-4.91251672706589	47	5	0.0276243093922652	181	6908	5096,217,1962,5095,56922	PCCB,ALDH2,EHHADH,PCCA,MCCC1
ko05230	Central carbon metabolism in cancer	0.00791235198834515	-4.83933019774113	67	6	0.0331491712707182	181	6908	4916,4233,5291,4914,8140,3099	NTRK3,MET,PIK3CB,NTRK1,SLC7A5,HK2
hsa05230	Central carbon metabolism in cancer	0.00791235198834515	-4.83933019774113	67	6	0.0331491712707182	181	6908	4916,4233,5291,4914,8140,3099	NTRK3,MET,PIK3CB,NTRK1,SLC7A5,HK2
ko04930	Type II diabetes mellitus	0.00803877399411915	-4.82347869571242	48	5	0.0276243093922652	181	6908	8660,5599,776,5291,3099	IRS2,MAPK8,CACNA1D,PIK3CB,HK2
hsa04930	Type II diabetes mellitus	0.00803877399411915	-4.82347869571242	48	5	0.0276243093922652	181	6908	8660,5599,776,5291,3099	IRS2,MAPK8,CACNA1D,PIK3CB,HK2
hsa00250	Alanine, aspartate and glutamate metabolism	0.0126636497185875	-4.36901961640476	35	4	0.0220994475138122	181	6908	84706,339983,440,2571	GPT2,NAT8L,ASNS,GAD1
ko00250	Alanine, aspartate and glutamate metabolism	0.0126636497185875	-4.36901961640476	35	4	0.0220994475138122	181	6908	84706,339983,440,2571	GPT2,NAT8L,ASNS,GAD1
hsa04152	AMPK signaling pathway	0.0151618592216609	-4.18897226633633	123	8	0.0441988950276243	181	6908	8660,3480,84254,9586,5522,5106,5291,5523	IRS2,IGF1R,CAMKK1,CREB5,PPP2R2C,PCK2,PIK3CB,PPP2R3A
ko04152	AMPK signaling pathway	0.0151618592216609	-4.18897226633633	123	8	0.0441988950276243	181	6908	8660,3480,84254,9586,5522,5106,5291,5523	IRS2,IGF1R,CAMKK1,CREB5,PPP2R2C,PCK2,PIK3CB,PPP2R3A
hsa04923	Regulation of lipolysis in adipocytes	0.0151718122111777	-4.18831603256021	56	5	0.0276243093922652	181	6908	8660,5742,5140,11343,5291	IRS2,PTGS1,PDE3B,MGLL,PIK3CB
ko04261	Adrenergic signaling in cardiomyocytes	0.0154415856589575	-4.17069104153959	148	9	0.0497237569060773	181	6908	776,9586,483,5522,785,9252,5330,5291,5523	CACNA1D,CREB5,ATP1B3,PPP2R2C,CACNB4,RPS6KA5,PLCB2,PIK3CB,PPP2R3A
hsa04261	Adrenergic signaling in cardiomyocytes	0.0154415856589575	-4.17069104153959	148	9	0.0497237569060773	181	6908	776,9586,483,5522,785,9252,5330,5291,5523	CACNA1D,CREB5,ATP1B3,PPP2R2C,CACNB4,RPS6KA5,PLCB2,PIK3CB,PPP2R3A
hsa04014	Ras signaling pathway	0.0158350324346191	-4.14553055070698	227	12	0.0662983425414365	181	6908	3363,5599,3480,2247,5922,5062,283455,22808,4233,5291,9965,285	HTR7,MAPK8,IGF1R,FGF2,RASA2,PAK2,KSR2,MRAS,MET,PIK3CB,FGF19,ANGPT2
ko00561	Glycerolipid metabolism	0.0186806301471156	-3.98026811296478	59	5	0.0276243093922652	181	6908	217,11343,1608,56895,23175	ALDH2,MGLL,DGKG,AGPAT4,LPIN1
hsa00561	Glycerolipid metabolism	0.0186806301471156	-3.98026811296478	59	5	0.0276243093922652	181	6908	217,11343,1608,56895,23175	ALDH2,MGLL,DGKG,AGPAT4,LPIN1
hsa05202	Transcriptional misregulation in cancer	0.0188882539927489	-3.96921503198158	179	10	0.0552486187845304	181	6908	8464,3480,4291,2119,4914,5090,4233,7048,1649,4208	SUPT3H,IGF1R,MLF1,ETV5,NTRK1,PBX3,MET,TGFBR2,DDIT3,MEF2C
ko05202	Transcriptional misregulation in cancer	0.0188882539927489	-3.96921503198158	179	10	0.0552486187845304	181	6908	8464,3480,4291,2119,4914,5090,4233,7048,1649,4208	SUPT3H,IGF1R,MLF1,ETV5,NTRK1,PBX3,MET,TGFBR2,DDIT3,MEF2C
ko04728	Dopaminergic synapse	0.0196767959661543	-3.92831520721031	129	8	0.0441988950276243	181	6908	5599,776,9586,5522,9575,4129,5330,5523	MAPK8,CACNA1D,CREB5,PPP2R2C,CLOCK,MAOB,PLCB2,PPP2R3A
hsa04728	Dopaminergic synapse	0.0196767959661543	-3.92831520721031	129	8	0.0441988950276243	181	6908	5599,776,9586,5522,9575,4129,5330,5523	MAPK8,CACNA1D,CREB5,PPP2R2C,CLOCK,MAOB,PLCB2,PPP2R3A
hsa04015	Rap1 signaling pathway	0.0224560638489641	-3.79619459663464	211	11	0.0607734806629834	181	6908	64411,3480,2247,5584,22808,4233,8631,5330,5291,9965,285	ARAP3,IGF1R,FGF2,PRKCI,MRAS,MET,SKAP1,PLCB2,PIK3CB,FGF19,ANGPT2
ko04015	Rap1 signaling pathway	0.0224560638489641	-3.79619459663464	211	11	0.0607734806629834	181	6908	64411,3480,2247,5584,22808,4233,8631,5330,5291,9965,285	ARAP3,IGF1R,FGF2,PRKCI,MRAS,MET,SKAP1,PLCB2,PIK3CB,FGF19,ANGPT2
ko01200	Carbon metabolism	0.0284672245128386	-3.55900187057799	113	7	0.0386740331491713	181	6908	84706,5096,1962,29968,26227,5095,3099	GPT2,PCCB,EHHADH,PSAT1,PHGDH,PCCA,HK2
hsa01200	Carbon metabolism	0.0284672245128386	-3.55900187057799	113	7	0.0386740331491713	181	6908	84706,5096,1962,29968,26227,5095,3099	GPT2,PCCB,EHHADH,PSAT1,PHGDH,PCCA,HK2
hsa04974	Protein digestion and absorption	0.0288353066317904	-3.54615471795742	89	6	0.0331491712707182	181	6908	1803,1287,483,1288,1293,1303	DPP4,COL4A5,ATP1B3,COL4A6,COL6A3,COL12A1
ko04974	Protein digestion and absorption	0.0288353066317904	-3.54615471795742	89	6	0.0331491712707182	181	6908	1803,1287,483,1288,1293,1303	DPP4,COL4A5,ATP1B3,COL4A6,COL6A3,COL12A1
hsa04910	Insulin signaling pathway	0.0292125406160906	-3.53315718875131	139	8	0.0441988950276243	181	6908	8660,5599,3099,5584,5577,5106,5140,5291	IRS2,MAPK8,HK2,PRKCI,PRKAR2B,PCK2,PDE3B,PIK3CB
ko04910	Insulin signaling pathway	0.0292125406160906	-3.53315718875131	139	8	0.0441988950276243	181	6908	8660,5599,3099,5584,5577,5106,5140,5291	IRS2,MAPK8,HK2,PRKCI,PRKAR2B,PCK2,PDE3B,PIK3CB
hsa04022	cGMP-PKG signaling pathway	0.0309890455206999	-3.47412150724699	167	9	0.0497237569060773	181	6908	8660,10335,776,9586,483,5140,5330,5291,4208	IRS2,MRVI1,CACNA1D,CREB5,ATP1B3,PDE3B,PLCB2,PIK3CB,MEF2C
ko04022	cGMP-PKG signaling pathway	0.0309890455206999	-3.47412150724699	167	9	0.0497237569060773	181	6908	8660,10335,776,9586,483,5140,5330,5291,4208	IRS2,MRVI1,CACNA1D,CREB5,ATP1B3,PDE3B,PLCB2,PIK3CB,MEF2C
hsa04115	p53 signaling pathway	0.0322753551291919	-3.43345133908171	68	5	0.0276243093922652	181	6908	545,83667,5366,4616,4194	ATR,SESN2,PMAIP1,GADD45B,MDM4
ko04115	p53 signaling pathway	0.0322753551291919	-3.43345133908171	68	5	0.0276243093922652	181	6908	545,83667,5366,4616,4194	ATR,SESN2,PMAIP1,GADD45B,MDM4
hsa00650	Butanoate metabolism	0.0326223858727425	-3.42275654305556	27	3	0.0165745856353591	181	6908	1962,2571,622	EHHADH,GAD1,BDH1
ko00650	Butanoate metabolism	0.0326223858727425	-3.42275654305556	27	3	0.0165745856353591	181	6908	1962,2571,622	EHHADH,GAD1,BDH1
ko00640	Propanoate metabolism	0.0358522630828107	-3.32834858749066	28	3	0.0165745856353591	181	6908	5096,1962,5095	PCCB,EHHADH,PCCA
hsa00640	Propanoate metabolism	0.0358522630828107	-3.32834858749066	28	3	0.0165745856353591	181	6908	5096,1962,5095	PCCB,EHHADH,PCCA
hsa05218	Melanoma	0.0378918926464085	-3.27301810411948	71	5	0.0276243093922652	181	6908	4233,3480,2247,5291,9965	MET,IGF1R,FGF2,PIK3CB,FGF19
ko05218	Melanoma	0.0378918926464085	-3.27301810411948	71	5	0.0276243093922652	181	6908	4233,3480,2247,5291,9965	MET,IGF1R,FGF2,PIK3CB,FGF19
ko04144	Endocytosis	0.0380168599512666	-3.26972553472585	258	12	0.0662983425414365	181	6908	64411,23527,3480,50807,7879,4914,5584,138429,857,4233,27128,7048	ARAP3,ACAP2,IGF1R,ASAP1,RAB7A,NTRK1,PRKCI,PIP5KL1,CAV1,MET,CYTH4,TGFBR2
hsa04144	Endocytosis	0.0380168599512666	-3.26972553472585	258	12	0.0662983425414365	181	6908	64411,23527,3480,50807,7879,4914,5584,138429,857,4233,27128,7048	ARAP3,ACAP2,IGF1R,ASAP1,RAB7A,NTRK1,PRKCI,PIP5KL1,CAV1,MET,CYTH4,TGFBR2
ko00330	Arginine and proline metabolism	0.0386932609038102	-3.25208983096243	49	4	0.0220994475138122	181	6908	384,112849,217,4129	ARG2,L3HYPDH,ALDH2,MAOB
hsa00330	Arginine and proline metabolism	0.0386932609038102	-3.25208983096243	49	4	0.0220994475138122	181	6908	384,112849,217,4129	ARG2,L3HYPDH,ALDH2,MAOB
hsa01230	Biosynthesis of amino acids	0.0419491533409034	-3.17129702884939	73	5	0.0276243093922652	181	6908	384,84706,29968,26227,4144	ARG2,GPT2,PSAT1,PHGDH,MAT2A
ko01230	Biosynthesis of amino acids	0.0419491533409034	-3.17129702884939	73	5	0.0276243093922652	181	6908	384,84706,29968,26227,4144	ARG2,GPT2,PSAT1,PHGDH,MAT2A
hsa01100	Metabolic pathways	0.0459251122442203	-3.08074320380728	1214	41	0.226519337016575	181	6908	384,84706,349565,1962,6480,4711,56922,9197,26227,23175,84002,8706,6184,440,622,8833,5742,8309,5106,2762,374378,5330,4129,2571,11343,1608,5096,217,29968,7378,5095,56895,79623,4144,10195,2591,23007,3099,339983,28999,138429	ARG2,GPT2,NMNAT3,EHHADH,ST6GAL1,NDUFB5,MCCC1,SLC33A1,PHGDH,LPIN1,B3GNT5,B3GALNT1,RPN1,ASNS,BDH1,GMPS,PTGS1,ACOX2,PCK2,GMDS,GALNT18,PLCB2,MAOB,GAD1,MGLL,DGKG,PCCB,ALDH2,PSAT1,UPP1,PCCA,AGPAT4,GALNT14,MAT2A,ALG3,GALNT3,PLCH1,HK2,NAT8L,KLF15,PIP5KL1
ko00512	Mucin type O-Glycan biosynthesis	0.0464858353747139	-3.06860762839113	31	3	0.0165745856353591	181	6908	2591,79623,374378	GALNT3,GALNT14,GALNT18
hsa00512	Mucin type O-Glycan biosynthesis	0.0464858353747139	-3.06860762839113	31	3	0.0165745856353591	181	6908	2591,79623,374378	GALNT3,GALNT14,GALNT18
ko00410	beta-Alanine metabolism	0.0464858353747139	-3.06860762839113	31	3	0.0165745856353591	181	6908	217,1962,2571	ALDH2,EHHADH,GAD1
hsa00410	beta-Alanine metabolism	0.0464858353747139	-3.06860762839113	31	3	0.0165745856353591	181	6908	217,1962,2571	ALDH2,EHHADH,GAD1
hsa04360	Axon guidance	0.0487741294275606	-3.02055524137524	127	7	0.0386740331491713	181	6908	2534,5361,4233,2047,8829,5062,9901	FYN,PLXNA1,MET,EPHB1,NRP1,PAK2,SRGAP3
ko04360	Axon guidance	0.0487741294275606	-3.02055524137524	127	7	0.0386740331491713	181	6908	2534,5361,4233,2047,8829,5062,9901	FYN,PLXNA1,MET,EPHB1,NRP1,PAK2,SRGAP3
ko03018	RNA degradation	0.0508247996590044	-2.97937086125603	77	5	0.0276243093922652	181	6908	131870,54464,80336,84186,170506	NUDT16,XRN1,PABPC1L,ZCCHC7,DHX36
hsa03018	RNA degradation	0.0508247996590044	-2.97937086125603	77	5	0.0276243093922652	181	6908	131870,54464,80336,84186,170506	NUDT16,XRN1,PABPC1L,ZCCHC7,DHX36
hsa05200	Pathways in cancer	0.0560280464947827	-2.88190288335663	397	16	0.0883977900552486	181	6908	5599,2736,2247,4914,10319,1287,7048,5291,9965,3914,2122,3480,3673,4233,5330,1288	MAPK8,GLI2,FGF2,NTRK1,LAMC3,COL4A5,TGFBR2,PIK3CB,FGF19,LAMB3,MECOM,IGF1R,ITGA2,MET,PLCB2,COL4A6
hsa04925	Aldosterone synthesis and secretion	0.060722297261025	-2.80144431293084	81	5	0.0276243093922652	181	6908	9586,776,57118,5330,3164	CREB5,CACNA1D,CAMK1D,PLCB2,NR4A1
ko04925	Aldosterone synthesis and secretion	0.060722297261025	-2.80144431293084	81	5	0.0276243093922652	181	6908	9586,776,57118,5330,3164	CREB5,CACNA1D,CAMK1D,PLCB2,NR4A1
hsa04068	FoxO signaling pathway	0.0616998960592178	-2.78547303268781	134	7	0.0386740331491713	181	6908	8660,5599,5106,3480,7048,5291,4616	IRS2,MAPK8,PCK2,IGF1R,TGFBR2,PIK3CB,GADD45B
hsa04931	Insulin resistance	0.0707344691185122	-2.64882228431588	111	6	0.0331491712707182	181	6908	8660,5599,57761,9586,5106,5291	IRS2,MAPK8,TRIB3,CREB5,PCK2,PIK3CB
hsa04726	Serotonergic synapse	0.0731938700775023	-2.61464360363206	112	6	0.0331491712707182	181	6908	3363,7220,5742,776,5330,4129	HTR7,TRPC1,PTGS1,CACNA1D,PLCB2,MAOB
hsa04310	Wnt signaling pathway	0.076545267093352	-2.56987298644038	141	7	0.0386740331491713	181	6908	166336,5599,4316,8607,79718,5330,22943	PRICKLE2,MAPK8,MMP7,RUVBL1,TBL1XR1,PLCB2,DKK1
ko04310	Wnt signaling pathway	0.076545267093352	-2.56987298644038	141	7	0.0386740331491713	181	6908	166336,5599,4316,8607,79718,5330,22943	PRICKLE2,MAPK8,MMP7,RUVBL1,TBL1XR1,PLCB2,DKK1
ko00260	Glycine, serine and threonine metabolism	0.0813691187981591	-2.50875945389889	39	3	0.0165745856353591	181	6908	29968,26227,4129	PSAT1,PHGDH,MAOB
hsa00260	Glycine, serine and threonine metabolism	0.0813691187981591	-2.50875945389889	39	3	0.0165745856353591	181	6908	29968,26227,4129	PSAT1,PHGDH,MAOB
hsa05205	Proteoglycans in cancer	0.0850306965312768	-2.46474295202353	203	9	0.0497237569060773	181	6908	3480,3339,2247,287,3673,22808,857,4233,5291	IGF1R,HSPG2,FGF2,ANK2,ITGA2,MRAS,CAV1,MET,PIK3CB
ko05205	Proteoglycans in cancer	0.0850306965312768	-2.46474295202353	203	9	0.0497237569060773	181	6908	3480,3339,2247,287,3673,22808,857,4233,5291	IGF1R,HSPG2,FGF2,ANK2,ITGA2,MRAS,CAV1,MET,PIK3CB
ko00380	Tryptophan metabolism	0.0863462392435689	-2.44939002781537	40	3	0.0165745856353591	181	6908	217,1962,4129	ALDH2,EHHADH,MAOB
hsa00380	Tryptophan metabolism	0.0863462392435689	-2.44939002781537	40	3	0.0165745856353591	181	6908	217,1962,4129	ALDH2,EHHADH,MAOB
ko04722	Neurotrophin signaling pathway	0.094608154936198	-2.35801160224013	120	6	0.0331491712707182	181	6908	5599,10019,4916,9252,5291,4914	MAPK8,SH2B3,NTRK3,RPS6KA5,PIK3CB,NTRK1
ko04071	Sphingolipid signaling pathway	0.094608154936198	-2.35801160224013	120	6	0.0331491712707182	181	6908	5599,2534,5522,5330,5291,5523	MAPK8,FYN,PPP2R2C,PLCB2,PIK3CB,PPP2R3A
hsa04722	Neurotrophin signaling pathway	0.094608154936198	-2.35801160224013	120	6	0.0331491712707182	181	6908	5599,10019,4916,9252,5291,4914	MAPK8,SH2B3,NTRK3,RPS6KA5,PIK3CB,NTRK1
hsa04071	Sphingolipid signaling pathway	0.094608154936198	-2.35801160224013	120	6	0.0331491712707182	181	6908	5599,2534,5522,5330,5291,5523	MAPK8,FYN,PPP2R2C,PLCB2,PIK3CB,PPP2R3A
ko00220	Arginine biosynthesis	0.0953446849486913	-2.35025669103064	20	2	0.0110497237569061	181	6908	84706,384	GPT2,ARG2
hsa00220	Arginine biosynthesis	0.0953446849486913	-2.35025669103064	20	2	0.0110497237569061	181	6908	84706,384	GPT2,ARG2
hsa01130	Biosynthesis of antibiotics	0.0997251082115859	-2.30533779609137	210	9	0.0497237569060773	181	6908	384,5096,217,1962,29968,5095,3099,5106,26227	ARG2,PCCB,ALDH2,EHHADH,PSAT1,PCCA,HK2,PCK2,PHGDH
hsa04110	Cell cycle	0.106453589195779	-2.24004617101257	124	6	0.0331491712707182	181	6908	545,902,10274,7029,4171,4616	ATR,CCNH,STAG1,TFDP2,MCM2,GADD45B
ko04110	Cell cycle	0.106453589195779	-2.24004617101257	124	6	0.0331491712707182	181	6908	545,902,10274,7029,4171,4616	ATR,CCNH,STAG1,TFDP2,MCM2,GADD45B
ko04920	Adipocytokine signaling pathway	0.110688541175528	-2.20103495704151	70	4	0.0220994475138122	181	6908	8660,5599,5106,84254	IRS2,MAPK8,PCK2,CAMKK1
hsa04920	Adipocytokine signaling pathway	0.110688541175528	-2.20103495704151	70	4	0.0220994475138122	181	6908	8660,5599,5106,84254	IRS2,MAPK8,PCK2,CAMKK1
hsa00562	Inositol phosphate metabolism	0.115034609744281	-2.16252224159845	71	4	0.0220994475138122	181	6908	23007,138429,5330,5291	PLCH1,PIP5KL1,PLCB2,PIK3CB
ko00562	Inositol phosphate metabolism	0.115034609744281	-2.16252224159845	71	4	0.0220994475138122	181	6908	138429,23007,5330,5291	PIP5KL1,PLCH1,PLCB2,PIK3CB
ko04921	Oxytocin signaling pathway	0.117660231793693	-2.13995419951808	157	7	0.0386740331491713	181	6908	776,57118,785,5330,84254,5291,4208	CACNA1D,CAMK1D,CACNB4,PLCB2,CAMKK1,PIK3CB,MEF2C
hsa04921	Oxytocin signaling pathway	0.117660231793693	-2.13995419951808	157	7	0.0386740331491713	181	6908	776,57118,785,5330,84254,5291,4208	CACNA1D,CAMK1D,CACNB4,PLCB2,CAMKK1,PIK3CB,MEF2C
hsa00340	Histidine metabolism	0.120752364312244	-2.11401340641552	23	2	0.0110497237569061	181	6908	217,4129	ALDH2,MAOB
hsa04964	Proximal tubule bicarbonate reclamation	0.120752364312244	-2.11401340641552	23	2	0.0110497237569061	181	6908	483,5106	ATP1B3,PCK2
ko04964	Proximal tubule bicarbonate reclamation	0.120752364312244	-2.11401340641552	23	2	0.0110497237569061	181	6908	483,5106	ATP1B3,PCK2
ko00340	Histidine metabolism	0.120752364312244	-2.11401340641552	23	2	0.0110497237569061	181	6908	217,4129	ALDH2,MAOB
ko04520	Adherens junction	0.123948028449915	-2.08789292663861	73	4	0.0220994475138122	181	6908	2534,4233,3480,7048	FYN,MET,IGF1R,TGFBR2
hsa04520	Adherens junction	0.123948028449915	-2.08789292663861	73	4	0.0220994475138122	181	6908	2534,4233,3480,7048	FYN,MET,IGF1R,TGFBR2
hsa00524	Butirosin and neomycin biosynthesis	0.12435399457919	-2.08462298557204	5	1	0.00552486187845304	181	6908	3099	HK2
ko00524	Butirosin and neomycin biosynthesis	0.12435399457919	-2.08462298557204	5	1	0.00552486187845304	181	6908	3099	HK2
hsa04611	Platelet activation	0.125589691400347	-2.07473510315436	130	6	0.0331491712707182	181	6908	5742,2534,5330,5291,3673,5584	PTGS1,FYN,PLCB2,PIK3CB,ITGA2,PRKCI
ko00510	N-Glycan biosynthesis	0.136382275648234	-1.99229348594412	49	3	0.0165745856353591	181	6908	10195,6184,6480	ALG3,RPN1,ST6GAL1
hsa00510	N-Glycan biosynthesis	0.136382275648234	-1.99229348594412	49	3	0.0165745856353591	181	6908	10195,6184,6480	ALG3,RPN1,ST6GAL1
hsa05142	Chagas disease (American trypanosomiasis)	0.136765514465121	-1.98948739281628	104	5	0.0276243093922652	181	6908	5599,5522,7048,5330,5291	MAPK8,PPP2R2C,TGFBR2,PLCB2,PIK3CB
ko05142	Chagas disease (American trypanosomiasis)	0.136765514465121	-1.98948739281628	104	5	0.0276243093922652	181	6908	5599,5522,7048,5330,5291	MAPK8,PPP2R2C,TGFBR2,PLCB2,PIK3CB
hsa00750	Vitamin B6 metabolism	0.147313856521798	-1.91518988986456	6	1	0.00552486187845304	181	6908	29968	PSAT1
ko00750	Vitamin B6 metabolism	0.147313856521798	-1.91518988986456	6	1	0.00552486187845304	181	6908	29968	PSAT1
hsa05100	Bacterial invasion of epithelial cells	0.14744986813077	-1.91426703805309	78	4	0.0220994475138122	181	6908	857,4233,5291,26084	CAV1,MET,PIK3CB,ARHGEF26
ko05100	Bacterial invasion of epithelial cells	0.14744986813077	-1.91426703805309	78	4	0.0220994475138122	181	6908	857,4233,5291,26084	CAV1,MET,PIK3CB,ARHGEF26
ko04024	cAMP signaling pathway	0.150954260562783	-1.89077839823401	199	8	0.0441988950276243	181	6908	5599,64411,776,5144,9586,483,5140,5291	MAPK8,ARAP3,CACNA1D,PDE4D,CREB5,ATP1B3,PDE3B,PIK3CB
hsa04024	cAMP signaling pathway	0.150954260562783	-1.89077839823401	199	8	0.0441988950276243	181	6908	5599,64411,776,5144,9586,483,5140,5291	MAPK8,ARAP3,CACNA1D,PDE4D,CREB5,ATP1B3,PDE3B,PIK3CB
hsa04141	Protein processing in endoplasmic reticulum	0.151445318010767	-1.88753065640889	168	7	0.0386740331491713	181	6908	5599,51726,6184,29927,64215,7095,1649	MAPK8,DNAJB11,RPN1,SEC61A1,DNAJC1,SEC62,DDIT3
ko04141	Protein processing in endoplasmic reticulum	0.151445318010767	-1.88753065640889	168	7	0.0386740331491713	181	6908	5599,51726,6184,29927,64215,7095,1649	MAPK8,DNAJB11,RPN1,SEC61A1,DNAJC1,SEC62,DDIT3
hsa00310	Lysine degradation	0.154865973188902	-1.86519522522602	52	3	0.0165745856353591	181	6908	217,1962,5352	ALDH2,EHHADH,PLOD2
ko00310	Lysine degradation	0.154865973188902	-1.86519522522602	52	3	0.0165745856353591	181	6908	217,1962,5352	ALDH2,EHHADH,PLOD2
hsa04725	Cholinergic synapse	0.165714857268382	-1.79748669490965	111	5	0.0276243093922652	181	6908	2534,9586,776,5330,5291	FYN,CREB5,CACNA1D,PLCB2,PIK3CB
hsa00630	Glyoxylate and dicarboxylate metabolism	0.166085575875916	-1.79525210613421	28	2	0.0110497237569061	181	6908	5096,5095	PCCB,PCCA
ko00630	Glyoxylate and dicarboxylate metabolism	0.166085575875916	-1.79525210613421	28	2	0.0110497237569061	181	6908	5096,5095	PCCB,PCCA
ko05410	Hypertrophic cardiomyopathy (HCM)	0.172527224350524	-1.75720023264148	83	4	0.0220994475138122	181	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa05410	Hypertrophic cardiomyopathy (HCM)	0.172527224350524	-1.75720023264148	83	4	0.0220994475138122	181	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa04911	Insulin secretion	0.18295097652984	-1.69853704984415	85	4	0.0220994475138122	181	6908	483,9586,776,5330	ATP1B3,CREB5,CACNA1D,PLCB2
hsa04012	ErbB signaling pathway	0.193577849390649	-1.64207552498998	87	4	0.0220994475138122	181	6908	5599,9542,5291,5062	MAPK8,NRG2,PIK3CB,PAK2
ko04012	ErbB signaling pathway	0.193577849390649	-1.64207552498998	87	4	0.0220994475138122	181	6908	5599,9542,5291,5062	MAPK8,NRG2,PIK3CB,PAK2
hsa04914	Progesterone-mediated oocyte maturation	0.193577849390649	-1.64207552498998	87	4	0.0220994475138122	181	6908	5599,3480,5140,5291	MAPK8,IGF1R,PDE3B,PIK3CB
ko04914	Progesterone-mediated oocyte maturation	0.193577849390649	-1.64207552498998	87	4	0.0220994475138122	181	6908	5599,3480,5140,5291	MAPK8,IGF1R,PDE3B,PIK3CB
hsa05416	Viral myocarditis	0.193924278036725	-1.64028751551158	58	3	0.0165745856353591	181	6908	857,1604,2534	CAV1,CD55,FYN
ko00051	Fructose and mannose metabolism	0.204121092172658	-1.58904187216058	32	2	0.0110497237569061	181	6908	2762,3099	GMDS,HK2
hsa00051	Fructose and mannose metabolism	0.204121092172658	-1.58904187216058	32	2	0.0110497237569061	181	6908	2762,3099	GMDS,HK2
ko05414	Dilated cardiomyopathy	0.204393430528766	-1.58770856143932	89	4	0.0220994475138122	181	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
hsa05414	Dilated cardiomyopathy	0.204393430528766	-1.58770856143932	89	4	0.0220994475138122	181	6908	7273,776,785,3673	TTN,CACNA1D,CACNB4,ITGA2
ko03015	mRNA surveillance pathway	0.215383250818881	-1.53533627578422	91	4	0.0220994475138122	181	6908	22916,80336,5522,5523	NCBP2,PABPC1L,PPP2R2C,PPP2R3A
hsa03015	mRNA surveillance pathway	0.215383250818881	-1.53533627578422	91	4	0.0220994475138122	181	6908	22916,80336,5522,5523	NCBP2,PABPC1L,PPP2R2C,PPP2R3A
hsa04390	Hippo signaling pathway	0.216536633949706	-1.52999553592462	154	6	0.0331491712707182	181	6908	2736,5522,7048,25937,1739,5584	GLI2,PPP2R2C,TGFBR2,WWTR1,DLG1,PRKCI
ko04390	Hippo signaling pathway	0.216536633949706	-1.52999553592462	154	6	0.0331491712707182	181	6908	2736,5522,7048,25937,1739,5584	GLI2,PPP2R2C,TGFBR2,WWTR1,DLG1,PRKCI
ko05210	Colorectal cancer	0.221188860217487	-1.50873837128254	62	3	0.0165745856353591	181	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
hsa05210	Colorectal cancer	0.221188860217487	-1.50873837128254	62	3	0.0165745856353591	181	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
ko05143	African trypanosomiasis	0.223489935651714	-1.49838889658352	34	2	0.0110497237569061	181	6908	3606,5330	IL18,PLCB2
hsa05143	African trypanosomiasis	0.223489935651714	-1.49838889658352	34	2	0.0110497237569061	181	6908	3606,5330	IL18,PLCB2
ko05020	Prion diseases	0.23322933178147	-1.4557330529065	35	2	0.0110497237569061	181	6908	2534,1958	FYN,EGR1
hsa05020	Prion diseases	0.23322933178147	-1.4557330529065	35	2	0.0110497237569061	181	6908	2534,1958	FYN,EGR1
hsa00072	Synthesis and degradation of ketone bodies	0.23331883065364	-1.45534938888004	10	1	0.00552486187845304	181	6908	622	BDH1
ko00072	Synthesis and degradation of ketone bodies	0.23331883065364	-1.45534938888004	10	1	0.00552486187845304	181	6908	622	BDH1
hsa05166	HTLV-I infection	0.235026038678997	-1.44805896808682	258	9	0.0497237569060773	181	6908	5599,1958,1739,545,467,22808,8829,7048,5291	MAPK8,EGR1,DLG1,ATR,ATF3,MRAS,NRP1,TGFBR2,PIK3CB
ko05166	HTLV-I infection	0.235026038678997	-1.44805896808682	258	9	0.0497237569060773	181	6908	5599,1958,1739,545,467,22808,8829,7048,5291	MAPK8,EGR1,DLG1,ATR,ATF3,MRAS,NRP1,TGFBR2,PIK3CB
hsa04924	Renin secretion	0.235102627431118	-1.44773314769627	64	3	0.0165745856353591	181	6908	776,5330,5140	CACNA1D,PLCB2,PDE3B
ko04924	Renin secretion	0.235102627431118	-1.44773314769627	64	3	0.0165745856353591	181	6908	776,5330,5140	CACNA1D,PLCB2,PDE3B
hsa03030	DNA replication	0.242994068130529	-1.41471824692502	36	2	0.0110497237569061	181	6908	5984,4171	RFC4,MCM2
ko03030	DNA replication	0.242994068130529	-1.41471824692502	36	2	0.0110497237569061	181	6908	5984,4171	RFC4,MCM2
ko05211	Renal cell carcinoma	0.249167467516104	-1.38963004827911	66	3	0.0165745856353591	181	6908	4233,5291,5062	MET,PIK3CB,PAK2
ko05212	Pancreatic cancer	0.249167467516104	-1.38963004827911	66	3	0.0165745856353591	181	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
hsa05212	Pancreatic cancer	0.249167467516104	-1.38963004827911	66	3	0.0165745856353591	181	6908	5599,7048,5291	MAPK8,TGFBR2,PIK3CB
hsa05211	Renal cell carcinoma	0.249167467516104	-1.38963004827911	66	3	0.0165745856353591	181	6908	4233,5291,5062	MET,PIK3CB,PAK2
hsa00430	Taurine and hypotaurine metabolism	0.253436153306004	-1.37264334839896	11	1	0.00552486187845304	181	6908	2571	GAD1
ko00430	Taurine and hypotaurine metabolism	0.253436153306004	-1.37264334839896	11	1	0.00552486187845304	181	6908	2571	GAD1
hsa04750	Inflammatory mediator regulation of TRP channels	0.255011390348603	-1.36644706678756	98	4	0.0220994475138122	181	6908	5599,5330,5291,4914	MAPK8,PLCB2,PIK3CB,NTRK1
ko04750	Inflammatory mediator regulation of TRP channels	0.255011390348603	-1.36644706678756	98	4	0.0220994475138122	181	6908	5599,5330,5291,4914	MAPK8,PLCB2,PIK3CB,NTRK1
ko00010	Glycolysis / Gluconeogenesis	0.256248271829435	-1.36160849263251	67	3	0.0165745856353591	181	6908	217,5106,3099	ALDH2,PCK2,HK2
hsa05031	Amphetamine addiction	0.256248271829435	-1.36160849263251	67	3	0.0165745856353591	181	6908	9586,776,4129	CREB5,CACNA1D,MAOB
hsa00010	Glycolysis / Gluconeogenesis	0.256248271829435	-1.36160849263251	67	3	0.0165745856353591	181	6908	217,5106,3099	ALDH2,PCK2,HK2
ko05031	Amphetamine addiction	0.256248271829435	-1.36160849263251	67	3	0.0165745856353591	181	6908	9586,776,4129	CREB5,CACNA1D,MAOB
hsa04380	Osteoclast differentiation	0.25934182780371	-1.34960828898113	131	5	0.0276243093922652	181	6908	5599,2534,7048,5291,140885	MAPK8,FYN,TGFBR2,PIK3CB,SIRPA
ko04380	Osteoclast differentiation	0.25934182780371	-1.34960828898113	131	5	0.0276243093922652	181	6908	5599,2534,7048,5291,140885	MAPK8,FYN,TGFBR2,PIK3CB,SIRPA
ko03013	RNA transport	0.268712849702359	-1.31411194276106	166	6	0.0331491712707182	181	6908	22916,8893,80336,8087,51068,1974	NCBP2,EIF2B5,PABPC1L,FXR1,NMD3,EIF4A2
hsa03013	RNA transport	0.268712849702359	-1.31411194276106	166	6	0.0331491712707182	181	6908	22916,8893,80336,8087,51068,1974	NCBP2,EIF2B5,PABPC1L,FXR1,NMD3,EIF4A2
ko03320	PPAR signaling pathway	0.270490622277461	-1.30751784940206	69	3	0.0165745856353591	181	6908	8309,5106,1962	ACOX2,PCK2,EHHADH
hsa03320	PPAR signaling pathway	0.270490622277461	-1.30751784940206	69	3	0.0165745856353591	181	6908	8309,5106,1962	ACOX2,PCK2,EHHADH
ko04960	Aldosterone-regulated sodium reabsorption	0.27236264023531	-1.30062086449708	39	2	0.0110497237569061	181	6908	483,5291	ATP1B3,PIK3CB
hsa04960	Aldosterone-regulated sodium reabsorption	0.27236264023531	-1.30062086449708	39	2	0.0110497237569061	181	6908	483,5291	ATP1B3,PIK3CB
ko04922	Glucagon signaling pathway	0.27244210245022	-1.30032915552596	101	4	0.0220994475138122	181	6908	9586,5106,5330,5140	CREB5,PCK2,PLCB2,PDE3B
hsa04922	Glucagon signaling pathway	0.27244210245022	-1.30032915552596	101	4	0.0220994475138122	181	6908	9586,5106,5330,5140	CREB5,PCK2,PLCB2,PDE3B
ko04723	Retrograde endocannabinoid signaling	0.27244210245022	-1.30032915552596	101	4	0.0220994475138122	181	6908	5599,776,5330,11343	MAPK8,CACNA1D,PLCB2,MGLL
hsa04723	Retrograde endocannabinoid signaling	0.27244210245022	-1.30032915552596	101	4	0.0220994475138122	181	6908	5599,776,5330,11343	MAPK8,CACNA1D,PLCB2,MGLL
hsa04664	Fc epsilon RI signaling pathway	0.277645939344266	-1.28140857648965	70	3	0.0165745856353591	181	6908	5599,2534,5291	MAPK8,FYN,PIK3CB
ko04664	Fc epsilon RI signaling pathway	0.277645939344266	-1.28140857648965	70	3	0.0165745856353591	181	6908	5599,2534,5291	MAPK8,FYN,PIK3CB
ko00620	Pyruvate metabolism	0.282152977129186	-1.2653058830395	40	2	0.0110497237569061	181	6908	217,5106	ALDH2,PCK2
hsa00620	Pyruvate metabolism	0.282152977129186	-1.2653058830395	40	2	0.0110497237569061	181	6908	217,5106	ALDH2,PCK2
hsa04066	HIF-1 signaling pathway	0.28417672265366	-1.25815897148119	103	4	0.0220994475138122	181	6908	3480,5291,285,3099	IGF1R,PIK3CB,ANGPT2,HK2
hsa04918	Thyroid hormone synthesis	0.28481996859208	-1.25589798746373	71	3	0.0165745856353591	181	6908	483,9586,5330	ATP1B3,CREB5,PLCB2
ko04918	Thyroid hormone synthesis	0.28481996859208	-1.25589798746373	71	3	0.0165745856353591	181	6908	483,9586,5330	ATP1B3,CREB5,PLCB2
ko04660	T cell receptor signaling pathway	0.2900731709804	-1.23762207410185	104	4	0.0220994475138122	181	6908	2534,5291,5062,1739	FYN,PIK3CB,PAK2,DLG1
hsa04660	T cell receptor signaling pathway	0.2900731709804	-1.23762207410185	104	4	0.0220994475138122	181	6908	2534,5291,5062,1739	FYN,PIK3CB,PAK2,DLG1
hsa05220	Chronic myeloid leukemia	0.29921239778583	-1.20660159729031	73	3	0.0165745856353591	181	6908	7048,5291,2122	TGFBR2,PIK3CB,MECOM
ko05220	Chronic myeloid leukemia	0.29921239778583	-1.20660159729031	73	3	0.0165745856353591	181	6908	7048,5291,2122	TGFBR2,PIK3CB,MECOM
ko00230	Purine metabolism	0.305114687962925	-1.18706754694687	174	6	0.0331491712707182	181	6908	8833,131870,2272,5144,5140,50940	GMPS,NUDT16,FHIT,PDE4D,PDE3B,PDE11A
hsa00230	Purine metabolism	0.305114687962925	-1.18706754694687	174	6	0.0331491712707182	181	6908	8833,131870,2272,5144,5140,50940	GMPS,NUDT16,FHIT,PDE4D,PDE3B,PDE11A
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.306425076351634	-1.18278200258586	74	3	0.0165745856353591	181	6908	776,785,3673	CACNA1D,CACNB4,ITGA2
ko04260	Cardiac muscle contraction	0.306425076351634	-1.18278200258586	74	3	0.0165745856353591	181	6908	483,776,785	ATP1B3,CACNA1D,CACNB4
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.306425076351634	-1.18278200258586	74	3	0.0165745856353591	181	6908	776,785,3673	CACNA1D,CACNB4,ITGA2
hsa04260	Cardiac muscle contraction	0.306425076351634	-1.18278200258586	74	3	0.0165745856353591	181	6908	483,776,785	ATP1B3,CACNA1D,CACNB4
hsa00603	Glycosphingolipid biosynthesis - globo series	0.310692114238333	-1.16895284353499	14	1	0.00552486187845304	181	6908	8706	B3GALNT1
ko00603	Glycosphingolipid biosynthesis - globo series	0.310692114238333	-1.16895284353499	14	1	0.00552486187845304	181	6908	8706	B3GALNT1
hsa04940	Type I diabetes mellitus	0.311435746952101	-1.16656223184786	43	2	0.0110497237569061	181	6908	5799,2571	PTPRN2,GAD1
ko04940	Type I diabetes mellitus	0.311435746952101	-1.16656223184786	43	2	0.0110497237569061	181	6908	5799,2571	PTPRN2,GAD1
ko00071	Fatty acid degradation	0.321147887673724	-1.13585355268211	44	2	0.0110497237569061	181	6908	217,1962	ALDH2,EHHADH
hsa00071	Fatty acid degradation	0.321147887673724	-1.13585355268211	44	2	0.0110497237569061	181	6908	217,1962	ALDH2,EHHADH
ko04668	TNF signaling pathway	0.325755868601589	-1.12160704747841	110	4	0.0220994475138122	181	6908	5599,9586,9252,5291	MAPK8,CREB5,RPS6KA5,PIK3CB
hsa04668	TNF signaling pathway	0.325755868601589	-1.12160704747841	110	4	0.0220994475138122	181	6908	5599,9586,9252,5291	MAPK8,CREB5,RPS6KA5,PIK3CB
hsa00604	Glycosphingolipid biosynthesis - ganglio series	0.328789695809762	-1.11233695506928	15	1	0.00552486187845304	181	6908	9197	SLC33A1
ko00604	Glycosphingolipid biosynthesis - ganglio series	0.328789695809762	-1.11233695506928	15	1	0.00552486187845304	181	6908	9197	SLC33A1
hsa03008	Ribosome biogenesis in eukaryotes	0.335321861008018	-1.09266442928151	78	3	0.0165745856353591	181	6908	54464,51068,55341	XRN1,NMD3,LSG1
ko03008	Ribosome biogenesis in eukaryotes	0.335321861008018	-1.09266442928151	78	3	0.0165745856353591	181	6908	54464,51068,55341	XRN1,NMD3,LSG1
hsa00983	Drug metabolism - other enzymes	0.340467362158638	-1.07743601067796	46	2	0.0110497237569061	181	6908	8833,7378	GMPS,UPP1
ko00983	Drug metabolism - other enzymes	0.340467362158638	-1.07743601067796	46	2	0.0110497237569061	181	6908	8833,7378	GMPS,UPP1
ko04932	Non-alcoholic fatty liver disease (NAFLD)	0.341423732944788	-1.07463095450372	147	5	0.0276243093922652	181	6908	8660,5599,5291,1649,4711	IRS2,MAPK8,PIK3CB,DDIT3,NDUFB5
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	0.341423732944788	-1.07463095450372	147	5	0.0276243093922652	181	6908	8660,5599,5291,1649,4711	IRS2,MAPK8,PIK3CB,DDIT3,NDUFB5
ko04724	Glutamatergic synapse	0.34971762469608	-1.05062923670875	114	4	0.0220994475138122	181	6908	7220,6507,776,5330	TRPC1,SLC1A3,CACNA1D,PLCB2
hsa04724	Glutamatergic synapse	0.34971762469608	-1.05062923670875	114	4	0.0220994475138122	181	6908	7220,6507,776,5330	TRPC1,SLC1A3,CACNA1D,PLCB2
ko04961	Endocrine and other factor-regulated calcium reabsorption	0.350065161566441	-1.04963596592314	47	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
hsa03420	Nucleotide excision repair	0.350065161566441	-1.04963596592314	47	2	0.0110497237569061	181	6908	5984,902	RFC4,CCNH
ko03420	Nucleotide excision repair	0.350065161566441	-1.04963596592314	47	2	0.0110497237569061	181	6908	5984,902	RFC4,CCNH
hsa04961	Endocrine and other factor-regulated calcium reabsorption	0.350065161566441	-1.04963596592314	47	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
ko00520	Amino sugar and nucleotide sugar metabolism	0.359615763567137	-1.02271914095186	48	2	0.0110497237569061	181	6908	2762,3099	GMDS,HK2
hsa00520	Amino sugar and nucleotide sugar metabolism	0.359615763567137	-1.02271914095186	48	2	0.0110497237569061	181	6908	2762,3099	GMDS,HK2
ko00120	Primary bile acid biosynthesis	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	8309	ACOX2
ko01210	2-Oxocarboxylic acid metabolism	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	84706	GPT2
hsa00360	Phenylalanine metabolism	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	4129	MAOB
hsa01210	2-Oxocarboxylic acid metabolism	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	84706	GPT2
ko00360	Phenylalanine metabolism	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	4129	MAOB
hsa00120	Primary bile acid biosynthesis	0.363579362334164	-1.01175767754666	17	1	0.00552486187845304	181	6908	8309	ACOX2
hsa05144	Malaria	0.369115060922116	-0.996646865329691	49	2	0.0110497237569061	181	6908	3606,4233	IL18,MET
ko05144	Malaria	0.369115060922116	-0.996646865329691	49	2	0.0110497237569061	181	6908	3606,4233	IL18,MET
hsa05030	Cocaine addiction	0.369115060922116	-0.996646865329691	49	2	0.0110497237569061	181	6908	9586,4129	CREB5,MAOB
ko05030	Cocaine addiction	0.369115060922116	-0.996646865329691	49	2	0.0110497237569061	181	6908	9586,4129	CREB5,MAOB
hsa04919	Thyroid hormone signaling pathway	0.373705816362066	-0.984286378356895	118	4	0.0220994475138122	181	6908	483,5330,5291,116931	ATP1B3,PLCB2,PIK3CB,MED12L
hsa05145	Toxoplasmosis	0.373705816362066	-0.984286378356895	118	4	0.0220994475138122	181	6908	10319,5599,5291,3914	LAMC3,MAPK8,PIK3CB,LAMB3
ko05145	Toxoplasmosis	0.373705816362066	-0.984286378356895	118	4	0.0220994475138122	181	6908	10319,5599,5291,3914	LAMC3,MAPK8,PIK3CB,LAMB3
hsa04210	Apoptosis	0.385683968514186	-0.95273697928259	85	3	0.0165745856353591	181	6908	5577,5291,4914	PRKAR2B,PIK3CB,NTRK1
ko04210	Apoptosis	0.385683968514186	-0.95273697928259	85	3	0.0165745856353591	181	6908	5577,5291,4914	PRKAR2B,PIK3CB,NTRK1
ko05132	Salmonella infection	0.385683968514186	-0.95273697928259	85	3	0.0165745856353591	181	6908	5599,3606,7879	MAPK8,IL18,RAB7A
hsa05132	Salmonella infection	0.385683968514186	-0.95273697928259	85	3	0.0165745856353591	181	6908	5599,3606,7879	MAPK8,IL18,RAB7A
hsa04978	Mineral absorption	0.387944528551201	-0.946892917231256	51	2	0.0110497237569061	181	6908	483,1181	ATP1B3,CLCN2
ko04978	Mineral absorption	0.387944528551201	-0.946892917231256	51	2	0.0110497237569061	181	6908	483,1181	ATP1B3,CLCN2
hsa03460	Fanconi anemia pathway	0.406525433448888	-0.900108785041565	53	2	0.0110497237569061	181	6908	55120,545	FANCL,ATR
ko03460	Fanconi anemia pathway	0.406525433448888	-0.900108785041565	53	2	0.0110497237569061	181	6908	55120,545	FANCL,ATR
hsa05215	Prostate cancer	0.414098186136236	-0.881652168695617	89	3	0.0165745856353591	181	6908	9586,3480,5291	CREB5,IGF1R,PIK3CB
ko05215	Prostate cancer	0.414098186136236	-0.881652168695617	89	3	0.0165745856353591	181	6908	9586,3480,5291	CREB5,IGF1R,PIK3CB
ko05130	Pathogenic Escherichia coli infection	0.424833110494847	-0.856058868365763	55	2	0.0110497237569061	181	6908	2534,7277	FYN,TUBA4A
hsa05130	Pathogenic Escherichia coli infection	0.424833110494847	-0.856058868365763	55	2	0.0110497237569061	181	6908	2534,7277	FYN,TUBA4A
hsa05032	Morphine addiction	0.428155080692142	-0.848269810963173	91	3	0.0165745856353591	181	6908	5144,5140,50940	PDE4D,PDE3B,PDE11A
ko04912	GnRH signaling pathway	0.428155080692142	-0.848269810963173	91	3	0.0165745856353591	181	6908	5599,776,5330	MAPK8,CACNA1D,PLCB2
hsa04912	GnRH signaling pathway	0.428155080692142	-0.848269810963173	91	3	0.0165745856353591	181	6908	5599,776,5330	MAPK8,CACNA1D,PLCB2
ko05032	Morphine addiction	0.428155080692142	-0.848269810963173	91	3	0.0165745856353591	181	6908	5144,5140,50940	PDE4D,PDE3B,PDE11A
hsa05223	Non-small cell lung cancer	0.433877659145594	-0.834992675990172	56	2	0.0110497237569061	181	6908	2272,5291	FHIT,PIK3CB
ko05223	Non-small cell lung cancer	0.433877659145594	-0.834992675990172	56	2	0.0110497237569061	181	6908	2272,5291	FHIT,PIK3CB
hsa04621	NOD-like receptor signaling pathway	0.442846080561338	-0.814533017253826	57	2	0.0110497237569061	181	6908	5599,3606	MAPK8,IL18
hsa05221	Acute myeloid leukemia	0.442846080561338	-0.814533017253826	57	2	0.0110497237569061	181	6908	5292,5291	PIM1,PIK3CB
ko05221	Acute myeloid leukemia	0.442846080561338	-0.814533017253826	57	2	0.0110497237569061	181	6908	5292,5291	PIM1,PIK3CB
ko04621	NOD-like receptor signaling pathway	0.442846080561338	-0.814533017253826	57	2	0.0110497237569061	181	6908	5599,3606	MAPK8,IL18
hsa00564	Glycerophospholipid metabolism	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	1608,56895,23175	DGKG,AGPAT4,LPIN1
ko04972	Pancreatic secretion	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	7220,483,5330	TRPC1,ATP1B3,PLCB2
hsa04972	Pancreatic secretion	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	7220,483,5330	TRPC1,ATP1B3,PLCB2
ko04713	Circadian entrainment	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	776,5330,9252	CACNA1D,PLCB2,RPS6KA5
hsa04713	Circadian entrainment	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	776,5330,9252	CACNA1D,PLCB2,RPS6KA5
ko00564	Glycerophospholipid metabolism	0.455900760325433	-0.785480124018062	95	3	0.0165745856353591	181	6908	1608,56895,23175	DGKG,AGPAT4,LPIN1
ko03430	Mismatch repair	0.457549190537156	-0.781870879746659	23	1	0.00552486187845304	181	6908	5984	RFC4
hsa03430	Mismatch repair	0.457549190537156	-0.781870879746659	23	1	0.00552486187845304	181	6908	5984	RFC4
hsa04730	Long-term depression	0.469273114015429	-0.756570347370223	60	2	0.0110497237569061	181	6908	3480,5330	IGF1R,PLCB2
ko04730	Long-term depression	0.469273114015429	-0.756570347370223	60	2	0.0110497237569061	181	6908	3480,5330	IGF1R,PLCB2
hsa04070	Phosphatidylinositol signaling system	0.476340732363593	-0.741621856537465	98	3	0.0165745856353591	181	6908	5330,1608,5291	PLCB2,DGKG,PIK3CB
ko04070	Phosphatidylinositol signaling system	0.476340732363593	-0.741621856537465	98	3	0.0165745856353591	181	6908	5330,1608,5291	PLCB2,DGKG,PIK3CB
ko04915	Estrogen signaling pathway	0.483076489504362	-0.72758027450465	99	3	0.0165745856353591	181	6908	9586,5330,5291	CREB5,PLCB2,PIK3CB
hsa04915	Estrogen signaling pathway	0.483076489504362	-0.72758027450465	99	3	0.0165745856353591	181	6908	9586,5330,5291	CREB5,PLCB2,PIK3CB
ko04810	Regulation of actin cytoskeleton	0.492284204186231	-0.7086990784808	214	6	0.0331491712707182	181	6908	22808,2247,5291,9965,3673,5062	MRAS,FGF2,PIK3CB,FGF19,ITGA2,PAK2
hsa04810	Regulation of actin cytoskeleton	0.492284204186231	-0.7086990784808	214	6	0.0331491712707182	181	6908	22808,2247,5291,9965,3673,5062	MRAS,FGF2,PIK3CB,FGF19,ITGA2,PAK2
ko04721	Synaptic vesicle cycle	0.49494440379425	-0.703309838288483	63	2	0.0110497237569061	181	6908	6812,6857	STXBP1,SYT1
hsa04721	Synaptic vesicle cycle	0.49494440379425	-0.703309838288483	63	2	0.0110497237569061	181	6908	6812,6857	STXBP1,SYT1
ko05231	Choline metabolism in cancer	0.496424350378089	-0.70032417291021	101	3	0.0165745856353591	181	6908	5599,1608,5291	MAPK8,DGKG,PIK3CB
hsa05231	Choline metabolism in cancer	0.496424350378089	-0.70032417291021	101	3	0.0165745856353591	181	6908	5599,1608,5291	MAPK8,DGKG,PIK3CB
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	0.499221777501152	-0.694704838076466	26	1	0.00552486187845304	181	6908	84002	B3GNT5
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	0.499221777501152	-0.694704838076466	26	1	0.00552486187845304	181	6908	84002	B3GNT5
hsa05214	Glioma	0.511618731986436	-0.670175595431647	65	2	0.0110497237569061	181	6908	3480,5291	IGF1R,PIK3CB
ko05214	Glioma	0.511618731986436	-0.670175595431647	65	2	0.0110497237569061	181	6908	3480,5291	IGF1R,PIK3CB
hsa00053	Ascorbate and aldarate metabolism	0.512392492154745	-0.668664361380048	27	1	0.00552486187845304	181	6908	217	ALDH2
ko00053	Ascorbate and aldarate metabolism	0.512392492154745	-0.668664361380048	27	1	0.00552486187845304	181	6908	217	ALDH2
hsa04550	Signaling pathways regulating pluripotency of stem cells	0.513651267545251	-0.666210711601209	142	4	0.0220994475138122	181	6908	6498,3480,2247,5291	SKIL,IGF1R,FGF2,PIK3CB
ko04550	Signaling pathways regulating pluripotency of stem cells	0.513651267545251	-0.666210711601209	142	4	0.0220994475138122	181	6908	6498,3480,2247,5291	SKIL,IGF1R,FGF2,PIK3CB
ko04620	Toll-like receptor signaling pathway	0.529022592529267	-0.636724140040965	106	3	0.0165745856353591	181	6908	5599,6696,5291	MAPK8,SPP1,PIK3CB
hsa04620	Toll-like receptor signaling pathway	0.529022592529267	-0.636724140040965	106	3	0.0165745856353591	181	6908	5599,6696,5291	MAPK8,SPP1,PIK3CB
hsa05161	Hepatitis B	0.535695537493998	-0.624189306363261	146	4	0.0220994475138122	181	6908	5599,9586,3339,5291	MAPK8,CREB5,HSPG2,PIK3CB
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	0.535947613455451	-0.623718858778395	68	2	0.0110497237569061	181	6908	5599,4233	MAPK8,MET
ko05120	Epithelial cell signaling in Helicobacter pylori infection	0.535947613455451	-0.623718858778395	68	2	0.0110497237569061	181	6908	5599,4233	MAPK8,MET
ko05216	Thyroid cancer	0.537709287605344	-0.620437222477025	29	1	0.00552486187845304	181	6908	4914	NTRK1
ko00760	Nicotinate and nicotinamide metabolism	0.537709287605344	-0.620437222477025	29	1	0.00552486187845304	181	6908	349565	NMNAT3
hsa00760	Nicotinate and nicotinamide metabolism	0.537709287605344	-0.620437222477025	29	1	0.00552486187845304	181	6908	349565	NMNAT3
hsa05216	Thyroid cancer	0.537709287605344	-0.620437222477025	29	1	0.00552486187845304	181	6908	4914	NTRK1
ko00052	Galactose metabolism	0.549873064161371	-0.598067819826164	30	1	0.00552486187845304	181	6908	3099	HK2
ko00020	Citrate cycle (TCA cycle)	0.549873064161371	-0.598067819826164	30	1	0.00552486187845304	181	6908	5106	PCK2
hsa00052	Galactose metabolism	0.549873064161371	-0.598067819826164	30	1	0.00552486187845304	181	6908	3099	HK2
hsa00020	Citrate cycle (TCA cycle)	0.549873064161371	-0.598067819826164	30	1	0.00552486187845304	181	6908	5106	PCK2
hsa04976	Bile secretion	0.559437579606902	-0.580823322052875	71	2	0.0110497237569061	181	6908	483,57552	ATP1B3,NCEH1
ko04976	Bile secretion	0.559437579606902	-0.580823322052875	71	2	0.0110497237569061	181	6908	483,57552	ATP1B3,NCEH1
ko00514	Other types of O-glycan biosynthesis	0.561718509843279	-0.576754426731793	31	1	0.00552486187845304	181	6908	6480	ST6GAL1
hsa04710	Circadian rhythm	0.561718509843279	-0.576754426731793	31	1	0.00552486187845304	181	6908	9575	CLOCK
ko04710	Circadian rhythm	0.561718509843279	-0.576754426731793	31	1	0.00552486187845304	181	6908	9575	CLOCK
hsa00514	Other types of O-glycan biosynthesis	0.561718509843279	-0.576754426731793	31	1	0.00552486187845304	181	6908	6480	ST6GAL1
hsa04917	Prolactin signaling pathway	0.56707837466498	-0.567257757884483	72	2	0.0110497237569061	181	6908	5599,5291	MAPK8,PIK3CB
ko04917	Prolactin signaling pathway	0.56707837466498	-0.567257757884483	72	2	0.0110497237569061	181	6908	5599,5291	MAPK8,PIK3CB
ko04145	Phagosome	0.567808926749753	-0.56597031342234	152	4	0.0220994475138122	181	6908	29927,7879,3673,7277	SEC61A1,RAB7A,ITGA2,TUBA4A
hsa04145	Phagosome	0.567808926749753	-0.56597031342234	152	4	0.0220994475138122	181	6908	29927,7879,3673,7277	SEC61A1,RAB7A,ITGA2,TUBA4A
hsa04971	Gastric acid secretion	0.582073862330737	-0.541157928082049	74	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
ko04971	Gastric acid secretion	0.582073862330737	-0.541157928082049	74	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
ko00350	Tyrosine metabolism	0.606079514711651	-0.500744089124952	35	1	0.00552486187845304	181	6908	4129	MAOB
hsa00350	Tyrosine metabolism	0.606079514711651	-0.500744089124952	35	1	0.00552486187845304	181	6908	4129	MAOB
hsa04270	Vascular smooth muscle contraction	0.613677470215974	-0.488285781657456	120	3	0.0165745856353591	181	6908	10335,776,5330	MRVI1,CACNA1D,PLCB2
ko04270	Vascular smooth muscle contraction	0.613677470215974	-0.488285781657456	120	3	0.0165745856353591	181	6908	10335,776,5330	MRVI1,CACNA1D,PLCB2
ko00040	Pentose and glucuronate interconversions	0.616453384615653	-0.483772572187631	36	1	0.00552486187845304	181	6908	217	ALDH2
hsa00040	Pentose and glucuronate interconversions	0.616453384615653	-0.483772572187631	36	1	0.00552486187845304	181	6908	217	ALDH2
hsa05010	Alzheimer's disease	0.618511606461627	-0.480439321825862	162	4	0.0220994475138122	181	6908	776,5330,23621,4711	CACNA1D,PLCB2,BACE1,NDUFB5
ko05010	Alzheimer's disease	0.618511606461627	-0.480439321825862	162	4	0.0220994475138122	181	6908	776,5330,23621,4711	CACNA1D,PLCB2,BACE1,NDUFB5
hsa00270	Cysteine and methionine metabolism	0.626555529173714	-0.467517874617325	37	1	0.00552486187845304	181	6908	4144	MAT2A
ko00270	Cysteine and methionine metabolism	0.626555529173714	-0.467517874617325	37	1	0.00552486187845304	181	6908	4144	MAT2A
hsa05203	Viral carcinogenesis	0.628330563242946	-0.46468887640977	205	5	0.0276243093922652	181	6908	9586,5366,5291,5922,1739	CREB5,PMAIP1,PIK3CB,RASA2,DLG1
ko05203	Viral carcinogenesis	0.628330563242946	-0.46468887640977	205	5	0.0276243093922652	181	6908	9586,5366,5291,5922,1739	CREB5,PMAIP1,PIK3CB,RASA2,DLG1
hsa04146	Peroxisome	0.644814060044137	-0.438793282748082	83	2	0.0110497237569061	181	6908	8309,1962	ACOX2,EHHADH
ko04146	Peroxisome	0.644814060044137	-0.438793282748082	83	2	0.0110497237569061	181	6908	8309,1962	ACOX2,EHHADH
ko04140	Regulation of autophagy	0.645972774265081	-0.436997921188159	39	1	0.00552486187845304	181	6908	30849	PIK3R4
hsa04140	Regulation of autophagy	0.645972774265081	-0.436997921188159	39	1	0.00552486187845304	181	6908	30849	PIK3R4
ko05219	Bladder cancer	0.664385708159698	-0.408892412371864	41	1	0.00552486187845304	181	6908	9252	RPS6KA5
hsa05219	Bladder cancer	0.664385708159698	-0.408892412371864	41	1	0.00552486187845304	181	6908	9252	RPS6KA5
ko04640	Hematopoietic cell lineage	0.670229950280176	-0.400134416106593	87	2	0.0110497237569061	181	6908	1604,3673	CD55,ITGA2
hsa04640	Hematopoietic cell lineage	0.670229950280176	-0.400134416106593	87	2	0.0110497237569061	181	6908	1604,3673	CD55,ITGA2
hsa04727	GABAergic synapse	0.676350891285881	-0.391043267659851	88	2	0.0110497237569061	181	6908	776,2571	CACNA1D,GAD1
ko04727	GABAergic synapse	0.676350891285881	-0.391043267659851	88	2	0.0110497237569061	181	6908	776,2571	CACNA1D,GAD1
hsa04540	Gap junction	0.676350891285881	-0.391043267659851	88	2	0.0110497237569061	181	6908	5330,7277	PLCB2,TUBA4A
ko04540	Gap junction	0.676350891285881	-0.391043267659851	88	2	0.0110497237569061	181	6908	5330,7277	PLCB2,TUBA4A
ko04970	Salivary secretion	0.682379689116835	-0.382169047144405	89	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
hsa04970	Salivary secretion	0.682379689116835	-0.382169047144405	89	2	0.0110497237569061	181	6908	483,5330	ATP1B3,PLCB2
ko05160	Hepatitis C	0.682667990510599	-0.381746642268218	133	3	0.0165745856353591	181	6908	5599,5522,5291	MAPK8,PPP2R2C,PIK3CB
hsa05160	Hepatitis C	0.682667990510599	-0.381746642268218	133	3	0.0165745856353591	181	6908	5599,5522,5291	MAPK8,PPP2R2C,PIK3CB
ko05152	Tuberculosis	0.687296601710622	-0.374989345271542	177	4	0.0220994475138122	181	6908	5599,3606,7879,1054	MAPK8,IL18,RAB7A,CEBPG
hsa05152	Tuberculosis	0.687296601710622	-0.374989345271542	177	4	0.0220994475138122	181	6908	5599,3606,7879,1054	MAPK8,IL18,RAB7A,CEBPG
ko04962	Vasopressin-regulated water reabsorption	0.690234331050683	-0.370724128826948	44	1	0.00552486187845304	181	6908	9586	CREB5
hsa00970	Aminoacyl-tRNA biosynthesis	0.690234331050683	-0.370724128826948	44	1	0.00552486187845304	181	6908	833	CARS
hsa04962	Vasopressin-regulated water reabsorption	0.690234331050683	-0.370724128826948	44	1	0.00552486187845304	181	6908	9586	CREB5
ko00970	Aminoacyl-tRNA biosynthesis	0.690234331050683	-0.370724128826948	44	1	0.00552486187845304	181	6908	833	CARS
ko04020	Calcium signaling pathway	0.695779670222351	-0.362722234537723	179	4	0.0220994475138122	181	6908	3363,80228,776,5330	HTR7,ORAI2,CACNA1D,PLCB2
hsa04020	Calcium signaling pathway	0.695779670222351	-0.362722234537723	179	4	0.0220994475138122	181	6908	3363,80228,776,5330	HTR7,ORAI2,CACNA1D,PLCB2
hsa03022	Basal transcription factors	0.698402685672635	-0.358959428999311	45	1	0.00552486187845304	181	6908	902	CCNH
ko03022	Basal transcription factors	0.698402685672635	-0.358959428999311	45	1	0.00552486187845304	181	6908	902	CCNH
ko04666	Fc gamma R-mediated phagocytosis	0.699919349643408	-0.356790165371598	92	2	0.0110497237569061	181	6908	50807,5291	ASAP1,PIK3CB
hsa04666	Fc gamma R-mediated phagocytosis	0.699919349643408	-0.356790165371598	92	2	0.0110497237569061	181	6908	50807,5291	ASAP1,PIK3CB
hsa04530	Tight junction	0.70665652683545	-0.347210548904894	138	3	0.0165745856353591	181	6908	22808,5522,5584	MRAS,PPP2R2C,PRKCI
ko04530	Tight junction	0.70665652683545	-0.347210548904894	138	3	0.0165745856353591	181	6908	22808,5522,5584	MRAS,PPP2R2C,PRKCI
hsa01212	Fatty acid metabolism	0.721644540655536	-0.326222587283391	48	1	0.00552486187845304	181	6908	1962	EHHADH
ko01212	Fatty acid metabolism	0.721644540655536	-0.326222587283391	48	1	0.00552486187845304	181	6908	1962	EHHADH
ko05016	Huntington's disease	0.728073711563499	-0.31735298376344	187	4	0.0220994475138122	181	6908	146754,9586,5330,4711	DNAH2,CREB5,PLCB2,NDUFB5
hsa05016	Huntington's disease	0.728073711563499	-0.31735298376344	187	4	0.0220994475138122	181	6908	146754,9586,5330,4711	DNAH2,CREB5,PLCB2,NDUFB5
hsa04913	Ovarian steroidogenesis	0.736140531609343	-0.306334238793316	50	1	0.00552486187845304	181	6908	3480	IGF1R
ko04913	Ovarian steroidogenesis	0.736140531609343	-0.306334238793316	50	1	0.00552486187845304	181	6908	3480	IGF1R
hsa04340	Hedgehog signaling pathway	0.743104451677775	-0.296918663151993	51	1	0.00552486187845304	181	6908	2736	GLI2
ko04340	Hedgehog signaling pathway	0.743104451677775	-0.296918663151993	51	1	0.00552486187845304	181	6908	2736	GLI2
ko04742	Taste transduction	0.743104451677775	-0.296918663151993	51	1	0.00552486187845304	181	6908	5330	PLCB2
hsa04742	Taste transduction	0.743104451677775	-0.296918663151993	51	1	0.00552486187845304	181	6908	5330	PLCB2
hsa05213	Endometrial cancer	0.749885565017547	-0.287834664069894	52	1	0.00552486187845304	181	6908	5291	PIK3CB
ko05213	Endometrial cancer	0.749885565017547	-0.287834664069894	52	1	0.00552486187845304	181	6908	5291	PIK3CB
ko05110	Vibrio cholerae infection	0.756488644482971	-0.279067756463913	53	1	0.00552486187845304	181	6908	29927	SEC61A1
hsa05110	Vibrio cholerae infection	0.756488644482971	-0.279067756463913	53	1	0.00552486187845304	181	6908	29927	SEC61A1
hsa05134	Legionellosis	0.769179176473912	-0.262431337300737	55	1	0.00552486187845304	181	6908	3606	IL18
ko05217	Basal cell carcinoma	0.769179176473912	-0.262431337300737	55	1	0.00552486187845304	181	6908	2736	GLI2
ko05134	Legionellosis	0.769179176473912	-0.262431337300737	55	1	0.00552486187845304	181	6908	3606	IL18
hsa05217	Basal cell carcinoma	0.769179176473912	-0.262431337300737	55	1	0.00552486187845304	181	6908	2736	GLI2
ko00500	Starch and sucrose metabolism	0.775275567705237	-0.254536741596695	56	1	0.00552486187845304	181	6908	3099	HK2
hsa00500	Starch and sucrose metabolism	0.775275567705237	-0.254536741596695	56	1	0.00552486187845304	181	6908	3099	HK2
ko00140	Steroid hormone biosynthesis	0.786992083339775	-0.239537089904052	58	1	0.00552486187845304	181	6908	6820	SULT2B1
hsa00140	Steroid hormone biosynthesis	0.786992083339775	-0.239537089904052	58	1	0.00552486187845304	181	6908	6820	SULT2B1
ko04630	Jak-STAT signaling pathway	0.788890742500644	-0.237127443643006	158	3	0.0165745856353591	181	6908	53833,5292,5291	IL20RB,PIM1,PIK3CB
hsa04630	Jak-STAT signaling pathway	0.788890742500644	-0.237127443643006	158	3	0.0165745856353591	181	6908	53833,5292,5291	IL20RB,PIM1,PIK3CB
ko05206	MicroRNAs in cancer	0.797629106916426	-0.226111567875459	297	6	0.0331491712707182	181	6908	8660,6541,5292,4233,9252,4194	IRS2,SLC7A1,PIM1,MET,RPS6KA5,MDM4
hsa05206	MicroRNAs in cancer	0.797629106916426	-0.226111567875459	297	6	0.0331491712707182	181	6908	8660,6541,5292,4233,9252,4194	IRS2,SLC7A1,PIM1,MET,RPS6KA5,MDM4
hsa04150	mTOR signaling pathway	0.798100931329086	-0.225520209168031	60	1	0.00552486187845304	181	6908	5291	PIK3CB
ko04150	mTOR signaling pathway	0.798100931329086	-0.225520209168031	60	1	0.00552486187845304	181	6908	5291	PIK3CB
ko04370	VEGF signaling pathway	0.803437340715191	-0.218856079776086	61	1	0.00552486187845304	181	6908	5291	PIK3CB
hsa04370	VEGF signaling pathway	0.803437340715191	-0.218856079776086	61	1	0.00552486187845304	181	6908	5291	PIK3CB
hsa00590	Arachidonic acid metabolism	0.808633461843959	-0.212409540188017	62	1	0.00552486187845304	181	6908	5742	PTGS1
ko00590	Arachidonic acid metabolism	0.808633461843959	-0.212409540188017	62	1	0.00552486187845304	181	6908	5742	PTGS1
hsa04623	Cytosolic DNA-sensing pathway	0.813692962787266	-0.206172179728788	63	1	0.00552486187845304	181	6908	3606	IL18
ko04623	Cytosolic DNA-sensing pathway	0.813692962787266	-0.206172179728788	63	1	0.00552486187845304	181	6908	3606	IL18
hsa05131	Shigellosis	0.818619416218466	-0.200135996394388	64	1	0.00552486187845304	181	6908	5599	MAPK8
ko05321	Inflammatory bowel disease (IBD)	0.823416301903629	-0.194293371562466	65	1	0.00552486187845304	181	6908	3606	IL18
hsa05321	Inflammatory bowel disease (IBD)	0.823416301903629	-0.194293371562466	65	1	0.00552486187845304	181	6908	3606	IL18
hsa04720	Long-term potentiation	0.828087009095467	-0.188637046669124	66	1	0.00552486187845304	181	6908	5330	PLCB2
ko04720	Long-term potentiation	0.828087009095467	-0.188637046669124	66	1	0.00552486187845304	181	6908	5330	PLCB2
ko00982	Drug metabolism - cytochrome P450	0.837063006425022	-0.17785593483234	68	1	0.00552486187845304	181	6908	4129	MAOB
hsa00982	Drug metabolism - cytochrome P450	0.837063006425022	-0.17785593483234	68	1	0.00552486187845304	181	6908	4129	MAOB
hsa05164	Influenza A	0.840140543631568	-0.174186087293073	174	3	0.0165745856353591	181	6908	5599,3606,5291	MAPK8,IL18,PIK3CB
ko05164	Influenza A	0.840140543631568	-0.174186087293073	174	3	0.0165745856353591	181	6908	5599,3606,5291	MAPK8,IL18,PIK3CB
ko04610	Complement and coagulation cascades	0.84137464323768	-0.172718244674313	69	1	0.00552486187845304	181	6908	1604	CD55
hsa04610	Complement and coagulation cascades	0.84137464323768	-0.172718244674313	69	1	0.00552486187845304	181	6908	1604	CD55
hsa04622	RIG-I-like receptor signaling pathway	0.845572799344549	-0.167741012227606	70	1	0.00552486187845304	181	6908	5599	MAPK8
ko04622	RIG-I-like receptor signaling pathway	0.845572799344549	-0.167741012227606	70	1	0.00552486187845304	181	6908	5599	MAPK8
hsa04662	B cell receptor signaling pathway	0.853640474497035	-0.158245163885068	72	1	0.00552486187845304	181	6908	5291	PIK3CB
ko04662	B cell receptor signaling pathway	0.853640474497035	-0.158245163885068	72	1	0.00552486187845304	181	6908	5291	PIK3CB
ko05034	Alcoholism	0.853800994490475	-0.158057139877418	179	3	0.0165745856353591	181	6908	9586,4129,84254	CREB5,MAOB,CAMKK1
hsa05034	Alcoholism	0.853800994490475	-0.158057139877418	179	3	0.0165745856353591	181	6908	9586,4129,84254	CREB5,MAOB,CAMKK1
ko05133	Pertussis	0.864962675342695	-0.145068922874079	75	1	0.00552486187845304	181	6908	5599	MAPK8
hsa05133	Pertussis	0.864962675342695	-0.145068922874079	75	1	0.00552486187845304	181	6908	5599	MAPK8
ko03040	Spliceosome	0.865737979730752	-0.144172980022673	132	2	0.0110497237569061	181	6908	22916,23350	NCBP2,U2SURP
hsa03040	Spliceosome	0.865737979730752	-0.144172980022673	132	2	0.0110497237569061	181	6908	22916,23350	NCBP2,U2SURP
ko05162	Measles	0.8712746728542	-0.137797998393943	134	2	0.0110497237569061	181	6908	2534,5291	FYN,PIK3CB
hsa05162	Measles	0.8712746728542	-0.137797998393943	134	2	0.0110497237569061	181	6908	2534,5291	FYN,PIK3CB
hsa04650	Natural killer cell mediated cytotoxicity	0.8712746728542	-0.137797998393943	134	2	0.0110497237569061	181	6908	2534,5291	FYN,PIK3CB
ko04650	Natural killer cell mediated cytotoxicity	0.8712746728542	-0.137797998393943	134	2	0.0110497237569061	181	6908	2534,5291	FYN,PIK3CB
ko04120	Ubiquitin mediated proteolysis	0.87918895641115	-0.128755436923446	137	2	0.0110497237569061	181	6908	7328,55120	UBE2H,FANCL
hsa04120	Ubiquitin mediated proteolysis	0.87918895641115	-0.128755436923446	137	2	0.0110497237569061	181	6908	7328,55120	UBE2H,FANCL
ko04514	Cell adhesion molecules (CAMs)	0.891392679019185	-0.114970231405376	142	2	0.0110497237569061	181	6908	26047,10666	CNTNAP2,CD226
hsa04514	Cell adhesion molecules (CAMs)	0.891392679019185	-0.114970231405376	142	2	0.0110497237569061	181	6908	26047,10666	CNTNAP2,CD226
ko04350	TGF-beta signaling pathway	0.89396264350363	-0.112091290471797	84	1	0.00552486187845304	181	6908	7048	TGFBR2
hsa04350	TGF-beta signaling pathway	0.89396264350363	-0.112091290471797	84	1	0.00552486187845304	181	6908	7048	TGFBR2
hsa05323	Rheumatoid arthritis	0.907302565349856	-0.0972792953556229	89	1	0.00552486187845304	181	6908	3606	IL18
ko05323	Rheumatoid arthritis	0.907302565349856	-0.0972792953556229	89	1	0.00552486187845304	181	6908	3606	IL18
hsa04064	NF-kappa B signaling pathway	0.912158631350531	-0.0919413661488912	91	1	0.00552486187845304	181	6908	4616	GADD45B
hsa04060	Cytokine-cytokine receptor interaction	0.922052144992041	-0.0811535006342955	265	4	0.0220994475138122	181	6908	53833,3606,4233,7048	IL20RB,IL18,MET,TGFBR2
ko04060	Cytokine-cytokine receptor interaction	0.922052144992041	-0.0811535006342955	265	4	0.0220994475138122	181	6908	53833,3606,4233,7048	IL20RB,IL18,MET,TGFBR2
hsa04916	Melanogenesis	0.931062705424084	-0.0714286512083061	100	1	0.00552486187845304	181	6908	5330	PLCB2
ko04916	Melanogenesis	0.931062705424084	-0.0714286512083061	100	1	0.00552486187845304	181	6908	5330	PLCB2
hsa00240	Pyrimidine metabolism	0.938108148866086	-0.0638900393235362	104	1	0.00552486187845304	181	6908	7378	UPP1
ko00240	Pyrimidine metabolism	0.938108148866086	-0.0638900393235362	104	1	0.00552486187845304	181	6908	7378	UPP1
hsa04114	Oocyte meiosis	0.950122096152783	-0.0511647803797425	112	1	0.00552486187845304	181	6908	3480	IGF1R
ko04114	Oocyte meiosis	0.950122096152783	-0.0511647803797425	112	1	0.00552486187845304	181	6908	3480	IGF1R
ko05168	Herpes simplex infection	0.956959577275187	-0.0439941274231691	184	2	0.0110497237569061	181	6908	5599,9575	MAPK8,CLOCK
hsa05168	Herpes simplex infection	0.956959577275187	-0.0439941274231691	184	2	0.0110497237569061	181	6908	5599,9575	MAPK8,CLOCK
ko04670	Leukocyte transendothelial migration	0.957582914856956	-0.0433429665256117	118	1	0.00552486187845304	181	6908	5291	PIK3CB
hsa04670	Leukocyte transendothelial migration	0.957582914856956	-0.0433429665256117	118	1	0.00552486187845304	181	6908	5291	PIK3CB
ko04062	Chemokine signaling pathway	0.95978725002512	-0.0410436336375559	187	2	0.0110497237569061	181	6908	5330,5291	PLCB2,PIK3CB
hsa04062	Chemokine signaling pathway	0.95978725002512	-0.0410436336375559	187	2	0.0110497237569061	181	6908	5330,5291	PLCB2,PIK3CB
hsa00190	Oxidative phosphorylation	0.959814347522703	-0.0410154012193096	120	1	0.00552486187845304	181	6908	4711	NDUFB5
ko00190	Oxidative phosphorylation	0.959814347522703	-0.0410154012193096	120	1	0.00552486187845304	181	6908	4711	NDUFB5
hsa05012	Parkinson's disease	0.96849567851082	-0.0320112581885933	129	1	0.00552486187845304	181	6908	4711	NDUFB5
ko05169	Epstein-Barr virus infection	0.969422911899478	-0.0310543207155702	199	2	0.0110497237569061	181	6908	5599,5291	MAPK8,PIK3CB
hsa05169	Epstein-Barr virus infection	0.969422911899478	-0.0310543207155702	199	2	0.0110497237569061	181	6908	5599,5291	MAPK8,PIK3CB
hsa03010	Ribosome	0.971728666659192	-0.02867866301876	133	1	0.00552486187845304	181	6908	11222	MRPL3
ko03010	Ribosome	0.971728666659192	-0.02867866301876	133	1	0.00552486187845304	181	6908	11222	MRPL3
ko04080	Neuroactive ligand-receptor interaction	0.995066686557534	-0.00494552240353233	276	2	0.0110497237569061	181	6908	3363,2894	HTR7,GRID1
hsa04080	Neuroactive ligand-receptor interaction	0.995066686557534	-0.00494552240353233	276	2	0.0110497237569061	181	6908	3363,2894	HTR7,GRID1
ko00232	Caffeine metabolism	0.999999999996265	-3.73474745211684e-12	5	0	0	181	6908
hsa00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999996265	-3.73474745211684e-12	5	0	0	181	6908
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.999999999996265	-3.73474745211684e-12	5	0	0	181	6908
hsa00232	Caffeine metabolism	0.999999999996265	-3.73474745211684e-12	5	0	0	181	6908
ko03410	Base excision repair	0.999999999996995	-3.00545512005029e-12	33	0	0	181	6908
hsa03410	Base excision repair	0.999999999996995	-3.00545512005029e-12	33	0	0	181	6908
hsa00770	Pantothenate and CoA biosynthesis	0.999999999997751	-2.24944833797575e-12	18	0	0	181	6908
ko00770	Pantothenate and CoA biosynthesis	0.999999999997751	-2.24944833797575e-12	18	0	0	181	6908
hsa00511	Other glycan degradation	0.999999999997751	-2.24944833797575e-12	18	0	0	181	6908
ko00511	Other glycan degradation	0.999999999997751	-2.24944833797575e-12	18	0	0	181	6908
ko00740	Riboflavin metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
hsa00290	Valine, leucine and isoleucine biosynthesis	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
ko00471	D-Glutamine and D-glutamate metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
hsa00471	D-Glutamine and D-glutamate metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
hsa00740	Riboflavin metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
ko00290	Valine, leucine and isoleucine biosynthesis	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
hsa00730	Thiamine metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
ko00730	Thiamine metabolism	0.999999999997991	-2.00866906759762e-12	4	0	0	181	6908
ko00785	Lipoic acid metabolism	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
hsa00780	Biotin metabolism	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
ko01220	Degradation of aromatic compounds	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
hsa01220	Degradation of aromatic compounds	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
hsa00785	Lipoic acid metabolism	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
ko00780	Biotin metabolism	0.999999999998352	-1.64780436677828e-12	3	0	0	181	6908
hsa00300	Lysine biosynthesis	0.99999999999965	-3.49922781722745e-13	2	0	0	181	6908
ko00300	Lysine biosynthesis	0.99999999999965	-3.49922781722745e-13	2	0	0	181	6908
hsa03450	Non-homologous end-joining	1.00000000000004	3.86192662391968e-14	13	0	0	181	6908
hsa00061	Fatty acid biosynthesis	1.00000000000004	3.86192662391968e-14	13	0	0	181	6908
ko03450	Non-homologous end-joining	1.00000000000004	3.86192662391968e-14	13	0	0	181	6908
ko00061	Fatty acid biosynthesis	1.00000000000004	3.86192662391968e-14	13	0	0	181	6908
hsa05320	Autoimmune thyroid disease	1.000000000003	3.00436985683867e-12	52	0	0	181	6908
ko05320	Autoimmune thyroid disease	1.000000000003	3.00436985683867e-12	52	0	0	181	6908
ko00900	Terpenoid backbone biosynthesis	1.00000000000397	3.9736962053859e-12	22	0	0	181	6908
hsa00900	Terpenoid backbone biosynthesis	1.00000000000397	3.9736962053859e-12	22	0	0	181	6908
hsa00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
ko00592	alpha-Linolenic acid metabolism	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
hsa00592	alpha-Linolenic acid metabolism	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
hsa00062	Fatty acid elongation	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
ko00062	Fatty acid elongation	1.00000000000408	4.08216774178979e-12	25	0	0	181	6908
hsa02010	ABC transporters	1.00000000000414	4.13707573632163e-12	44	0	0	181	6908
ko02010	ABC transporters	1.00000000000414	4.13707573632163e-12	44	0	0	181	6908
hsa03050	Proteasome	1.00000000000414	4.13707573632163e-12	44	0	0	181	6908
ko03050	Proteasome	1.00000000000414	4.13707573632163e-12	44	0	0	181	6908
ko00860	Porphyrin and chlorophyll metabolism	1.00000000000435	4.35019277821724e-12	42	0	0	181	6908
hsa00860	Porphyrin and chlorophyll metabolism	1.00000000000435	4.35019277821724e-12	42	0	0	181	6908
ko05332	Graft-versus-host disease	1.00000000000511	5.10801782926106e-12	41	0	0	181	6908
hsa04975	Fat digestion and absorption	1.00000000000511	5.10801782926106e-12	41	0	0	181	6908
hsa05332	Graft-versus-host disease	1.00000000000511	5.10801782926106e-12	41	0	0	181	6908
ko04975	Fat digestion and absorption	1.00000000000511	5.10801782926106e-12	41	0	0	181	6908
hsa05310	Asthma	1.00000000000559	5.58601581190944e-12	30	0	0	181	6908
ko05310	Asthma	1.00000000000559	5.58601581190944e-12	30	0	0	181	6908
hsa00531	Glycosaminoglycan degradation	1.00000000000567	5.66684693632201e-12	19	0	0	181	6908
ko00531	Glycosaminoglycan degradation	1.00000000000567	5.66684693632201e-12	19	0	0	181	6908
hsa00591	Linoleic acid metabolism	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
ko00030	Pentose phosphate pathway	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
hsa03440	Homologous recombination	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
ko03440	Homologous recombination	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
ko00591	Linoleic acid metabolism	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
hsa00030	Pentose phosphate pathway	1.00000000000594	5.93625918603693e-12	29	0	0	181	6908
ko00790	Folate biosynthesis	1.00000000000688	6.88478317651455e-12	14	0	0	181	6908
hsa00790	Folate biosynthesis	1.00000000000688	6.88478317651455e-12	14	0	0	181	6908
hsa05150	Staphylococcus aureus infection	1.00000000000714	7.13979798510787e-12	55	0	0	181	6908
ko05150	Staphylococcus aureus infection	1.00000000000714	7.13979798510787e-12	55	0	0	181	6908
hsa00460	Cyanoamino acid metabolism	1.00000000000893	8.93182106880181e-12	7	0	0	181	6908
ko00460	Cyanoamino acid metabolism	1.00000000000893	8.93182106880181e-12	7	0	0	181	6908
ko04130	SNARE interactions in vesicular transport	1.00000000000932	9.32425234399662e-12	34	0	0	181	6908
hsa04130	SNARE interactions in vesicular transport	1.00000000000932	9.32425234399662e-12	34	0	0	181	6908
hsa05340	Primary immunodeficiency	1.0000000000094	9.40233589563606e-12	36	0	0	181	6908
ko05340	Primary immunodeficiency	1.0000000000094	9.40233589563606e-12	36	0	0	181	6908
ko03020	RNA polymerase	1.00000000001027	1.02690271184094e-11	31	0	0	181	6908
hsa03020	RNA polymerase	1.00000000001027	1.02690271184094e-11	31	0	0	181	6908
hsa00472	D-Arginine and D-ornithine metabolism	1.00000000001087	1.0866214178451e-11	1	0	0	181	6908
ko00472	D-Arginine and D-ornithine metabolism	1.00000000001087	1.0866214178451e-11	1	0	0	181	6908
ko05033	Nicotine addiction	1.00000000001092	1.09206053717516e-11	40	0	0	181	6908
hsa05033	Nicotine addiction	1.00000000001092	1.09206053717516e-11	40	0	0	181	6908
hsa00670	One carbon pool by folate	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
hsa00100	Steroid biosynthesis	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
ko00670	One carbon pool by folate	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
ko00100	Steroid biosynthesis	1.00000000001096	1.09593992203444e-11	20	0	0	181	6908
hsa05140	Leishmaniasis	1.00000000001135	1.13513350333314e-11	72	0	0	181	6908
ko05140	Leishmaniasis	1.00000000001135	1.13513350333314e-11	72	0	0	181	6908
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000001205	1.20495206128287e-11	11	0	0	181	6908
hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000001205	1.20495206128287e-11	11	0	0	181	6908
ko01040	Biosynthesis of unsaturated fatty acids	1.00000000001224	1.22412888317003e-11	23	0	0	181	6908
hsa04614	Renin-angiotensin system	1.00000000001224	1.22412888317003e-11	23	0	0	181	6908
ko04614	Renin-angiotensin system	1.00000000001224	1.22412888317003e-11	23	0	0	181	6908
hsa01040	Biosynthesis of unsaturated fatty acids	1.00000000001224	1.22412888317003e-11	23	0	0	181	6908
ko04744	Phototransduction	1.00000000001271	1.27132461652185e-11	28	0	0	181	6908
hsa04744	Phototransduction	1.00000000001271	1.27132461652185e-11	28	0	0	181	6908
hsa00910	Nitrogen metabolism	1.00000000001316	1.31625950919392e-11	17	0	0	181	6908
hsa00450	Selenocompound metabolism	1.00000000001316	1.31625950919392e-11	17	0	0	181	6908
ko00910	Nitrogen metabolism	1.00000000001316	1.31625950919392e-11	17	0	0	181	6908
ko00450	Selenocompound metabolism	1.00000000001316	1.31625950919392e-11	17	0	0	181	6908
hsa05330	Allograft rejection	1.00000000001379	1.37897633778627e-11	37	0	0	181	6908
ko05330	Allograft rejection	1.00000000001379	1.37897633778627e-11	37	0	0	181	6908
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1.00000000001413	1.41270397617538e-11	24	0	0	181	6908
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1.00000000001413	1.41270397617538e-11	24	0	0	181	6908
hsa04977	Vitamin digestion and absorption	1.00000000001413	1.41270397617538e-11	24	0	0	181	6908
ko04977	Vitamin digestion and absorption	1.00000000001413	1.41270397617538e-11	24	0	0	181	6908
ko00565	Ether lipid metabolism	1.00000000001418	1.41800660924915e-11	45	0	0	181	6908
hsa00565	Ether lipid metabolism	1.00000000001418	1.41800660924915e-11	45	0	0	181	6908
hsa04122	Sulfur relay system	1.00000000001587	1.58722880685466e-11	10	0	0	181	6908
ko00920	Sulfur metabolism	1.00000000001587	1.58722880685466e-11	10	0	0	181	6908
ko04122	Sulfur relay system	1.00000000001587	1.58722880685466e-11	10	0	0	181	6908
hsa00920	Sulfur metabolism	1.00000000001587	1.58722880685466e-11	10	0	0	181	6908
hsa05014	Amyotrophic lateral sclerosis (ALS)	1.00000000001614	1.61369930552727e-11	51	0	0	181	6908
hsa00480	Glutathione metabolism	1.00000000001614	1.61369930552727e-11	51	0	0	181	6908
ko05014	Amyotrophic lateral sclerosis (ALS)	1.00000000001614	1.61369930552727e-11	51	0	0	181	6908
ko00480	Glutathione metabolism	1.00000000001614	1.61369930552727e-11	51	0	0	181	6908
hsa04950	Maturity onset diabetes of the young	1.0000000000162	1.62017086440392e-11	26	0	0	181	6908
ko04950	Maturity onset diabetes of the young	1.0000000000162	1.62017086440392e-11	26	0	0	181	6908
hsa00980	Metabolism of xenobiotics by cytochrome P450	1.00000000001693	1.69292512272356e-11	74	0	0	181	6908
ko00980	Metabolism of xenobiotics by cytochrome P450	1.00000000001693	1.69292512272356e-11	74	0	0	181	6908
ko04672	Intestinal immune network for IgA production	1.00000000001736	1.73632802804498e-11	47	0	0	181	6908
hsa04672	Intestinal immune network for IgA production	1.00000000001736	1.73632802804498e-11	47	0	0	181	6908
ko00600	Sphingolipid metabolism	1.00000000001736	1.73632802804498e-11	47	0	0	181	6908
hsa00600	Sphingolipid metabolism	1.00000000001736	1.73632802804498e-11	47	0	0	181	6908
ko04330	Notch signaling pathway	1.00000000001785	1.78481502512892e-11	48	0	0	181	6908
hsa04330	Notch signaling pathway	1.00000000001785	1.78481502512892e-11	48	0	0	181	6908
hsa04612	Antigen processing and presentation	1.00000000001816	1.81639119131509e-11	77	0	0	181	6908
ko04612	Antigen processing and presentation	1.00000000001816	1.81639119131509e-11	77	0	0	181	6908
ko04320	Dorso-ventral axis formation	1.00000000001872	1.87149258289579e-11	27	0	0	181	6908
hsa04320	Dorso-ventral axis formation	1.00000000001872	1.87149258289579e-11	27	0	0	181	6908
ko04966	Collecting duct acid secretion	1.00000000001872	1.87149258289579e-11	27	0	0	181	6908
hsa04966	Collecting duct acid secretion	1.00000000001872	1.87149258289579e-11	27	0	0	181	6908
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000001929	1.92930776286139e-11	15	0	0	181	6908
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000001929	1.92930776286139e-11	15	0	0	181	6908
hsa00830	Retinol metabolism	1.00000000001961	1.96051758029683e-11	65	0	0	181	6908
ko00830	Retinol metabolism	1.00000000001961	1.96051758029683e-11	65	0	0	181	6908
hsa05204	Chemical carcinogenesis	1.00000000002124	2.12421849366213e-11	81	0	0	181	6908
ko05204	Chemical carcinogenesis	1.00000000002124	2.12421849366213e-11	81	0	0	181	6908
hsa04740	Olfactory transduction	1.00000000002647	2.64720975211184e-11	404	0	0	181	6908
ko04740	Olfactory transduction	1.00000000002647	2.64720975211184e-11	404	0	0	181	6908
hsa04142	Lysosome	1.00000000002725	2.7245532840028e-11	123	0	0	181	6908
ko04142	Lysosome	1.00000000002725	2.7245532840028e-11	123	0	0	181	6908
hsa05322	Systemic lupus erythematosus	1.00000000002955	2.95449993398757e-11	134	0	0	181	6908
ko05322	Systemic lupus erythematosus	1.00000000002955	2.95449993398757e-11	134	0	0	181	6908
